Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study

Valle, Rafael F.; Carignan, Charles S; Wright, Thomas C.

doi:10.1016/s0015-0282(01)02858-8

Cited by 162 publications

(79 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Its inner polyethylene terephthalate fibres elicit a benign tissue ingrowth that blocks the fallopian tubes in about 3 months, resulting in permanent tubal occlusion. 1 The fibres are wound around a flexible stainless steel inner coil and are surrounded by a dynamic outer nickel titanium alloy coil (Nitinol) that expands to anchor the device across the uterotubal junction during the time required for the completion of fibrosis. The micro-insert is attached to a guide wire and sheathed by a hydrophilic delivery catheter used only for placement and designed to improve access to the tube.…”

Section: Methodsmentioning

confidence: 99%

Success rate and patient satisfaction with the Essure™ sterilisation in an outpatient setting: a prospective study of 857 women

Miño

Arjona

Cordón

et al. 2007

BJOG

View full text Add to dashboard Cite

After 857 women with Essure system inserted for tubal obstruction as a method of sterilization in an outpatient setting, insertion is achieved in close to 99% of the women. Physician described the procedure as very difficult in 15% of the cases, mainly due to anatomical tubal anomalis or tubal spasm, and women felt highly satisfied in all cases.Keywords Essure, female sterilization, hysteroscopy, satisfaction.Please cite this paper as: Miño M, Arjona J, Cordó n J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure TM sterilisation in an outpatient setting: a prospective study of 857 women. BJOG 2007;114: 763-766.

show abstract

Section: Methodsmentioning

confidence: 99%

Success rate and patient satisfaction with the Essure™ sterilisation in an outpatient setting: a prospective study of 857 women

Miño

Arjona

Cordón

et al. 2007

BJOG

View full text Add to dashboard Cite

show abstract

“…Placement could be achieved in 97%, which is even higher than the overall success rates in the normal population [3,5]. A few small retrospective feasibility studies elucidated the advantage to leave the IUD in place, but their outcomes were also less successful [6,7].…”

Section: Discussionmentioning

confidence: 95%

“…Fibrotic tissue is formed in the proximal tube. This chronic fibrotic reaction will be completed in all patients after 3 months after the placement of the device and will block both tubes in all patients: 96.5% at 3 months and 100% at 6 months [3].…”

Section: Introductionmentioning

confidence: 99%

Hysteroscopic sterilization with Essure® device in situ: a challenge?

et al. 2010

View full text Add to dashboard Cite

Hysteroscopic sterilization through the Essure® method is preferably performed in the outpatient department without any form of anesthesia. This approach requires the hysteroscopic skills of the gynecologist to use the vaginoscopic route. Initially, the manufacturer advised to remove any type of intrauterine device (IUD), 1 month before the procedure, to prevent difficult procedures and also to increase the success rate of placement. This observational prospective study analyzed the outcome in women in where the IUD was left in the uterus during the sterilization. During a period of 2 years, all women have been included consecutively in seven public hospitals located in France and the Netherlands. During this procedure, 32 out of 239 IUDs had to be removed to finish the sterilization successfully. The placement success rate was 97%. Placement failures were not related to the IUD being present at the time of the procedure. At confirmation tests 3 months after insertion of the Essure®, only five tubes were still patent. No complications were registered. Pain was recorded, and women responded well on oral nonsteroidal anti-inflammatory drug medication. The IUD did not need to be removed before the start of the hysteroscopic sterilization; only in case the procedure could not be completed, the IUD had to be removed during the sterilization itself. Placement rate was 97.1%.

show abstract

“…Este método de esterilización permanente ha sido aprobado por la Comunidad Europea (febrero 2001) y por la FDA (noviembre 2002), debido a su demostrada seguridad y efectividad (11,12,(14)(15)(16)(17)(18).…”

Section: Discussionunclassified

Nuevo Método De Esterilización Ambulatoria Y Permanente Con Técnica Histeroscópica, Essure

et al. 2005

Rev. chil. obstet. ginecol.

View full text Add to dashboard Cite

RESUMENObjetivo: Presentamos nuestra experiencia en la inserción de un nuevo método de esterilización permanente vía histeroscópica, Essure. Se revisa el procedimiento de inserción, complicaciones, tolerancia, grado de satisfacción y aceptación de usuaria. Método: Entre enero y febrero de 2005 se realizaron 5 esterilizaciones con Essure en la Unidad de Ginecología y Obstetricia de Clínica Las Condes. Resultados: Se colocó el dispositivo en ambas trompas exitosamente en todas las pacientes. Rango de tiempo operatorio: 10-30 minutos. No hubo complicaciones intraoperatorias. Todas expresaron buena tolerancia y un alto grado de satisfacción frente al procedimiento de inserción histeroscópico. Lo recomendarían por su rapidez, carácter ambulatorio y ausencia de dolor. Durante el postoperatorio un caso presentó metrorragia leve y algia pélvica moderada. Conclusiones: Nuestra primera experiencia en la inserción del dispositivo intra tubario mostró ser un procedimiento bien tolerado y con buena aceptación por las pacientes.PALABRAS CLAVES: Esterilización permanente, dispositivo intra tubario, histeroscopía, esterilización ambulatoria SUMMARYObjective: We presented our experience in Essure insertion, a new hysteroscopic permanent sterilization method. We reviewed insertion procedure, complications, degree of tolerance and acceptance by user. Method: Between January and February 2005 five sterilizations cases with Essure were made in Las Condes Clinic. Results: The device in both tubes in all women was placed. Operative time was between 10 and 30 minutes. Intraoperative complications did not appear. All patients expressed very good tolerance and a high degree of satisfaction with insertion procedure. The reason because they would recommend it was: rapidity, ambulatory and absence of pain. During postoperative time one case presented weighs uterus bleeding and moderate pain. Conclusion: Our first experience in hysteroscopic intra Fallopian tube device insertion showed a procedure with very good tolerance and acceptance by the patients.KEY WORDS: Permanent sterilization, intra Fallopian tube device, hysteroscopy, ambulatory sterilization Casos Clínicos INTRODUCCIÓNLa esterilización tubaria ha sido el método de anticoncepción permanente más utilizado en el mundo (1, 2). Aprovechando las bondades de la cirugía mínimamente invasiva, actualmente se realiza mayoritariamente por vía laparoscópica (3, 4). Sin embargo, al igual que la esterilización tubaria efectuada por minilaparatomía abdominal, se debe exponer a la paciente a incisiones abdominales y anestesia, las cuales no están exentas del riesgo de complicaciones (5, 6).

show abstract

Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study

Cited by 162 publications

References 10 publications

Success rate and patient satisfaction with the Essure™ sterilisation in an outpatient setting: a prospective study of 857 women

Success rate and patient satisfaction with the Essure™ sterilisation in an outpatient setting: a prospective study of 857 women

Hysteroscopic sterilization with Essure® device in situ: a challenge?

Nuevo Método De Esterilización Ambulatoria Y Permanente Con Técnica Histeroscópica, Essure

Contact Info

Product

Resources

About